Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

Hallux Valgus clinical trials

1 of 5 indexed Hallux Valgus trials are currently recruiting.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 1 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Hallux Valgus: 5 US clinical trials tracked, 1 recruiting.

Hallux Valgus is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Treace Medical Concepts, running 2 of these trials.

Enrollment posture brief

Registry condition hallux-valgus

OPEN 1 | RECR 20% | LATE 0 | EARLY 0 | RANK #3391 | SPON 2

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (20% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Hallux Valgus (this)20%
Open-enrollment share among volume-matched conditions near Hallux Valgus

Hallux Valgus lists 1 open slots (20% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Hallux Valgus on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Hallux Valgus is recruiting below its size-band peers.

    1 of 5 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Hallux Valgus research.

    Treace Medical Concepts accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Most Hallux Valgus trials plan to enrol fewer than 100 people.

    Median target enrolment is 31 among the 5 trials that report a genuine target (sentinel values excluded). 4 of those (80%) plan for fewer than 100 participants.

  4. Hallux Valgus research is mostly interventional.

    4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Hallux Valgus records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Lapiplasty Device
2 trials
Experimental Treatment Device
1 trials
Treatment of metatarsus adductus and hallux valgus with the Adductoplasty™ Procedure in combination with the Lapiplasty® Procedure Device
1 trials

US sites by state

Facility locations filed on Hallux Valgus trials. A trial with sites in several states counts in each.

Texas 3 trials
Iowa 3 trials
Pennsylvania 2 trials
Ohio 2 trials
Missouri 2 trials
Colorado 2 trials
California 2 trials
Nevada 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Hallux Valgus page

5 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hallux Valgus condition card totals 5 registered trials; most-linked intervention Lapiplasty; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.